Average Co-Inventor Count = 4.23
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (18 from 2,198 patents)
2. Affinium Pharmaceuticals, Inc. (15 from 33 patents)
3. Cytokinetics, Inc. (10 from 257 patents)
4. Glaxosmithkline LLC (9 from 356 patents)
5. Smithkline Beckman Corporation (3 from 207 patents)
6. Glaxosmithkline Intellectual Property (no.2) Limited (2 from 95 patents)
7. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
8. Smithkline Beechman Corporation (1 from 7 patents)
54 patents:
1. 12247033 - Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors
2. 9790212 - Enhancer of zeste homolog 2 inhibitors
3. 9505745 - Enhancer of zeste homolog 2 inhibitors
4. 9402836 - Indoles
5. 9382234 - Enhancer of Zeste Homolog 2 inhibitors
6. 9073924 - Azaindazoles
7. 9018382 - Indazoles
8. 8975291 - Indoles
9. 8846935 - Indazoles
10. 8765792 - Indoles
11. 8637509 - Azaindazoles
12. 8633236 - Compounds, compositions and methods
13. 8404837 - Quinoline derivatives as P13 kinase inhibitors
14. 8329928 - Compounds, compositions and methods
15. 8173646 - FAB I inhibitors